122921-57-7

122921-57-7 - Names and Identifiers

Name	TV-BPK (Travoprost)
Synonyms	TV-BPK (Travoprost) [1,1'-Biphenyl]-4-carboxylic acid hexahydro-2-oxo-4-[3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-5-yl ester (3aR,4R,5R,6aS)-2-oxo-4-{(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl}hexahydro-2H-cyclopenta[b]furan-5-yl biphenyl-4-carboxylate [1,1'-Biphenyl]-4-carboxylic acid,(3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-5-yl ester [1,1'-Biphenyl]-4-carboxylic acid, (3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-5-yl ester rel-[1,1'-Biphenyl]-4-carboxylic acid (3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-5-yl ester
CAS	122921-57-7 40695-33-8 54142-64-2
InChI	InChI=1/C31H25F3O6/c32-31(33,34)22-7-4-8-24(15-22)38-18-23(35)13-14-25-26-16-29(36)39-28(26)17-27(25)40-30(37)21-11-9-20(10-12-21)19-5-2-1-3-6-19/h1-15,25-28H,16-18H2/b14-13+/t25-,26-,27-,28+/m1/s1

122921-57-7 - Physico-chemical Properties

Molecular Formula	C31H25F3O6
Molar Mass	550.52
Density	1.37
Melting Point	128-129℃
Boling Point	699.684°C at 760 mmHg
Flash Point	362.651°C
Vapor Presure	0mmHg at 25°C
Storage Condition	2-8℃
Sensitive	IRRITANT
Refractive Index	1.604
MDL	MFCD16620488

122921-57-7 - Introduction

Hexahydro-2-oxo-4-[3-oxo-4-[3-(trifluoromethyl) phenoxy]-1-butenyl]-2H-cyclopenta [B] furan-5-yl [1,1 '-biphenyl]-4-carboxylate, chemical formula C27H23FO5.

Nature:
1. Appearance: white solid.
2. Melting point: about 170-175°C.
3. Solubility: Soluble in organic solvents such as chloroform and dimethylformamide, insoluble in water.

Use:
Hexahydro-2-oxo-4-[3-oxo-4-[3-(trifluoromethyl) phenoxy]-1-butenyl]-2H-cyclopenta [B] furan-5-yl [1,1 '-biphenyl]-4-formate is widely used in the fields of medicine, pesticide and cosmetics. It has antiviral, antioxidant and anti-inflammatory effects, and can be used in medicine to treat viral infections and inflammation-related diseases.

Preparation Method:
The synthesis method of hexahydro-2-oxo-4-[3-oxo-4-[3-(trifluoromethyl) phenoxy]-1-butenyl]-2H-cyclopenta [B] furan -5-yl [1,1 '-biphenyl]-4-formate is more complicated, which requires detailed experimental conditions and reaction steps. In general, the target product can be synthesized by different organic synthesis methods.

Safety Information:
Since hexahydro-2-oxo-4-[3-oxo-4-[3-(trifluoromethyl) phenoxy]-1-butenyl]-2H-cyclopenta [B] furan-5-yl [1,1 '-biphenyl]-4-formate is a chemical substance, it should be handled in accordance with safe laboratory specifications, wear appropriate protective equipment. The toxicity and harmfulness of this compound have not been studied in detail, so it should be stored in a dark, dry and well-ventilated place, away from fire and high temperature. In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical attention.

Last Update：2024-04-09 21:04:16